• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    VolitionRX Limited Common Stock (NY:VNRX)

    0.7181 -0.0816 (-10.20%)
    Official Closing Price Updated: 8:00 PM EDT, Jul 31, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about VolitionRX Limited Common Stock

    < Previous 1 2 Next >
    BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Highlights Growing Clinical Evidence Supporting Nu.Q NETs Test
    Via Investor Brand Network
    BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Study Highlights Prognostic Value of Nu.Q Cancer Assay in Lung Cancer
    Via Investor Brand Network
    BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Collaborates with Sysmex to Advance Nu.Q® NETs Assay Development
    Via Investor Brand Network
    BioMedNewsBreaks — VolitionRx Ltd. (NYSE American: VNRX) Expands Patent Portfolio with Ebola Triage Application
    Via Investor Brand Network
    Topics Intellectual Property
    BioMedNewsBreaks — VolitionRx Ltd. (NYSE American: VNRX) Highlights Clinical and Commercial Progress Across Diagnostics Portfolio
    Via Investor Brand Network
    News headline image
    BioMedNewsBreaks — VolitionRx Ltd. (NYSE American: VNRX) Reports High Accuracy In Feline Cancer Blood Test Study
    Via Investor Brand Network
    InvestorNewsBreaks – VolitionRx Ltd. (NYSE American: VNRX) Reports Finger-Prick Breakthrough for Nucleosome Detection in Sepsis
    Via Investor Brand Network
    InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Reports Over 95% Early-Stage Cancer Detection Using Capture-Seq Technology
    Via Investor Brand Network
    InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Reports Breakthrough in Liquid Biopsy With Over 99% Cancer DNA Purity
    Via Investor Brand Network
    InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Completes Automation Validation for Nu.Q Vet Cancer Test in Japan
    Via Investor Brand Network
    BioMedNewsBreaks — VolitionRx Ltd. (NYSE American: VNRX) Reports Multi-Pillar Clinical and Commercial Progress
    Via Investor Brand Network
    InvestorNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Appoints MBL as Distributor for Nu.Q(R) Discover Assays in Japan
    Via Investor Brand Network
    BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Prepares Reimbursement Submission for Nu.Q Cancer Assays in France
    Via Investor Brand Network
    BioMedNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Study Shows Nu.Q Vet Feline Test Accurately Detects Lymphoma in Cats
    Via Investor Brand Network
    BioMedNewsBreaks — Volition Solves Liquid Biopsy’s “Needle in a Haystack” Problem; Achieves 180-fold (18,000%) Enrichment
    Via Investor Brand Network
    BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Nu.Q NETs Assay Selected for France’s National Sepsis Detection Initiative
    Via Investor Brand Network
    InvestorNewsBreaks – VolitionRx (NYSE American: VNRX) Signs Co-Marketing and Services Agreement with Hologic (NASDAQ: HOLX)
    Via Investor Brand Network
    BioMedNewsBreaks — VolitionRx (NYSE American: VNRX) Signs Deal with Worldwide Leader in Specialized Diagnostics
    Via Investor Brand Network
    News headline image
    Life Sciences Virtual Investor Forum Agenda Announced for September 19th
    Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    BioMedNewsBreaks — VolitionRx Limited (NYSE American: VNRX) appoints PharmaVentures for Capture PCR(TM) and Oncology Portfolio Licensing
    Via Investor Brand Network
    BioMedNewsBreaks — VolitionRx Limited (NYSE American: VNRX) Highlights Latest Achievements in Mid-Year Review
    Via Investor Brand Network
    Topics Intellectual Property
    News headline image
    Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
    Via ACCESSWIRE
    VolitionRx Ltd. (NYSE American: VNRX) Featured in Coverage of the EF Hutton Annual Global Conference
    Via Investor Brand Network
    News headline image
    Keynotes, Educational Panels and 77 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 25-27, 2023 at the Horseshoe Hotel & Casino in Las Vegas, NV
    Via ACCESSWIRE
    News headline image
    Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
    Company Executives Share Vision and Answer Questions at VirtualInvestorConferences.com 
    From Virtual Investor Conferences
    Via GlobeNewswire
    News headline image
    Sidoti & Company, LLC Announces Registration Now Open for March Small-Cap and May Micro-Cap Conferences
    Via ACCESSWIRE
    News headline image
    Sidoti's January Micro-Cap Conference
    Via ACCESSWIRE
    News headline image
    Xenetic Biosciences, Inc. Announces Signing of Patent Assignment Related to Collaboration With VolitionRx Limited and CLS Therapeutics
    Via ACCESSWIRE
    News headline image
    Sidoti's August Micro-Cap Virtual Conference
    Via ACCESSWIRE
    News headline image
    Xenetic Biosciences, Inc. and VolitionRx Limited Collaborate to Develop NETs-Targeted Adoptive Cell Therapies for the Treatment of Cancer
    Via ACCESSWIRE
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.